ArmonAir Digihaler: payments to doctors
Payments that named ArmonAir Digihaler as the associated drug or biological, reported under the Sunshine Act for program years 2019–2025.
- Total reported
- $614K
- Providers
- 1,134
- Transactions
- 1,785
- Average per transaction
- $344
The per-transaction average — $344 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 1,134 providers the average total is $542, but that average hides a very steep distribution.
Companies reporting these payments
| Company | Total reported | Share |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | $614,421 | 100.0% |